Co-Diagnostics, Inc.

Healthcare · Medical Devices · United States

Last price 0.3667 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.91M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In...